Odyssey Health (ODYY) Net Income towards Common Stockholders Growth (5y) (2019 - 2026)
Odyssey Health (ODYY) Net Income towards Common Stockholders Growth (5y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.81 Bn | 193.21 Bn | 7.27 Bn |
| 2 | Stryker | 127.76 Bn | 124.28 Bn | 4.50 Bn |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.43 Bn | 32.49 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.88 Bn | 31.77 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn |
| 9 | Steris | 23.11 Bn | 22.63 Bn | 684.20 Mn |
| 10 | Odyssey Health | 1.01 Mn | 711,880.61 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 15.57% |
| Jan 31, 2026 | 7.32% |
| Oct 31, 2025 | 10.95% |
| Jul 31, 2025 | 30.97% |
| Apr 30, 2025 | 53.98% |
| Jan 31, 2025 | 55.33% |
| Oct 31, 2024 | 28.01% |
| Jul 31, 2024 | 11.63% |
| Apr 30, 2024 | -68.09% |
| Jan 31, 2024 | 163.12% |
| Oct 31, 2023 | -50.58% |
| Jul 31, 2023 | -52.44% |
| Apr 30, 2023 | -77.17% |
| Jan 31, 2023 | -46.56% |
| Oct 31, 2022 | -102.31% |
| Jul 31, 2022 | -78.57% |
| Apr 30, 2022 | -107.79% |
| Jan 31, 2022 | -133.95% |
| Oct 31, 2021 | -137.32% |
| Jul 31, 2021 | -133.89% |